Related Experiment Video
Updated: May 28, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Maspin expression in epithelial skin tumours: an immunohistochemical study
Asmaa Gaber Abdou1, Alaa Hassan Maraee, Mohamed Abd El-Monaem Shoeib
1Department of Pathology, Faculty of Medicine, Menofiya University, Shebein Elkom, Egypt.
Journal of Cutaneous and Aesthetic Surgery
|October 7, 2011
Summary
Maspin, a tumor suppressor, is expressed in healthy skin but reduced in skin cancers like basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Its expression is linked to squamous differentiation and may play a role in inhibiting cancer progression.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Maspin, a serpin family protease inhibitor, is implicated in suppressing carcinoma invasion, metastasis, angiogenesis, and inducing apoptosis.
- Understanding maspin's role in skin cancers is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate maspin expression in cutaneous basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) using immunohistochemistry.
- To correlate maspin expression patterns with specific clinicopathological features of these skin cancers.
Main Methods:
- Immunohistochemical analysis of maspin expression in 43 skin cancer patients (25 BCC, 18 SCC) and 10 healthy controls.
- Quantitative assessment of maspin positivity, intensity, and subcellular localization (cytoplasmic vs. nuclear).
Main Results:
- Significantly lower maspin expression in malignant skin tumors (60.5%) compared to healthy controls (100%).
- Maspin expression was higher in SCC (77.8%) than BCC (48%), with stronger intensity favoring SCC.
- Nuclear maspin staining observed in both BCC and SCC, particularly in older patients and adenoid SCC variants.
Conclusions:
- Maspin expression is associated with terminal squamous differentiation in skin cancers.
- Nuclear maspin staining in BCC and SCC suggests a potential tumor suppressor role, particularly in BCC.
- Maspin's altered expression in skin cancers highlights its potential as a diagnostic and prognostic biomarker.
